The Medicines Law & Policy team has published widely on a variety of issues related to access to and innovation on essential medicines, including: international intellectual property policy and its impact on access to medicines, in particular on policies coming out of the World Trade Organization, the World Health Organization, and the World Intellectual Property Organization; options for innovative ways to create incentives for research and development, in particular on medical products for diseases disproportionately affecting developing countries; and on the lessons the access to HIV movement has for the access to medicines crises of the future. Below is a selection of relevant publications by ML&P staff.
Watch Ellen ‘t Hoen’s TED Talk “Pool medical patents, save lives.”
All Publications
-
Protect against market exclusivity in the fight against COVID-19: Nature Medicine, May 2020
-
Patent challenges in the procurement and supply of generic new essential medicines and lessons from HIV in the southern African development community (SADC) region: Journal of Pharmaceutical Policy and Practice, November 2018.
-
Practical Applications of the Flexibilities of the Agreement on Trade-Related Aspects of Intellectual Property Rights: Lessons beyond HIV for access to new essential medicines: University of Groningen, the Netherlands, 2018.
-
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation: Journal of Pharmaceutical Policy and Practice, 28 June 2017
-
The Lancet Commissions: Essential medicines for universal health coverage: The Lancet, 28 January 2017
-
Private Patents and Public Health: Changing intellectual property rules for access to medicines: Health Action International, January 2016
-
Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions: Journal of Public Health Policy, November 2015
-
Access to Cancer Treatment: A study of medicine pricing issues with recommendations for improving access to cancer medication: Report prepared for Oxfam, 2 May 2014
-
We urge WHO to act on cytomegalovirus retinitis: The Lancet Global Health, February 2014
-
A quiet revolution in global public health: The World Health Organization’s Prequalification of Medicines Programme: Journal of Public Health Policy, May 2014
-
Burden of HIV-Related Cytomegalovirus Retinitis in Resource-Limited Settings: A Systematic Review: Clinical Infectious Diseases, 29 July 2013
-
Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?: PLoS Med, 15 May 2012
-
Driving a decade of change: HIV/AIDS, patents and access to medicines for all: Journal of the International AIDS Society, 27 March 2011
-
Registering New Drugs for Low-Income Countries: The African Challenge: PLoS Medicine, February 2011
-
The UNITAID Patent Pool Initiative: Bringing Patents Together for the Common Good: The Open AIDS Journal, 19 January 2010
-
The global politics of pharmaceutical monopoly power: drug patents, access, innovation and the application of the WTO Doha Declaration on TRIPS and public health: AMB Publishers,2009
-
Determining the Patent Status of Essential Medicines in Developing Countries: WHO Health Economics and Drugs Series No. 017, 2004
-
TRIPS, Pharmaceutical Patents and Access to Essential Medicines: Seattle, Doha and Beyond: Chapter in the book Economics of AIDS and access to HIV-AIDS care in developing countries: issues and challenges, 25 June 2003
-
25 years of the WHO essential medicines lists: progress and challenges: The Lancet, 17 May 2003
-
Drug Patents Under the Spotlight. Sharing practical knowledge about pharmaceutical patents: Médecins Sans Frontières, May 2003
-
Globalization, patents and drugs : an annotated bibliography: World Health Organization Department of Essential Drugs and Medicines Policy, 2001
-
Pharmaceuticals and the WTO TRIPS Agreement: Questions and Answers: UNAIDS and WHO, March 2000
-
Patent situation of HIV/AIDS-related drugs in 80 countries: UNAIDS and WHO, January 2000
-
Globalization, patents and drugs : an annotated bibliography: Health Economics and Drugs, EDM Series No. 9, 1999
-
Essential drugs in the new international economic environment: Bulletin of the World Health Organization, 1999
-
Globalization and Access to Drugs. Perspectives on the WTO/TRIPS Agreement – Health Economics and Drugs Series, No. 007 (Revised): World Health Organization Action Programme on Essential Drugs, 1998